Analyses of real-world genomic and clinical data from 54,185 patients with solid cancer receiving care within the Japanese healthcare system reveal the clinical utility of genomic sequencing and highlight differences across 81 tumor types
- Yuki Saito
- Sara Horie
- Keisuke Kataoka